Heart MRI study seeks answers for lingering COVID symptoms
NCT ID NCT05164744
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study uses cardiac MRI and other tests to examine heart and lung function in 510 COVID-19 survivors who had symptoms like shortness of breath or cough. The goal is to find out why some people have lasting cardiopulmonary problems after COVID-19. Participants will undergo imaging and questionnaires over several years to track changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help identify why some COVID-19 survivors have lasting heart and lung symptoms, pointing toward targeted therapies.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly benefit participants. Results may not apply to all COVID-19 survivors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONAVIRUS DISEASE 2019 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
New York Presbyterian Queens
RECRUITINGNew York, New York, 10021, United States
Contact Email: •••••@•••••
-
New York Presbyterian-Brooklyn Methodist Hospital
RECRUITINGBrooklyn, New York, 11215-3609, United States
Contact Email: •••••@•••••
-
Weill Cornell Medicine/New-York Presbyterian Hospital
RECRUITINGNew York, New York, 10021, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?